-+ 0.00%
-+ 0.00%
-+ 0.00%

CytoSorbents Expects Operating Cash Flow Breakeven in Second Half of 2026

PUBT·11/07/2026 18:29:38
Listen to the news
CytoSorbents Expects Operating Cash Flow Breakeven in Second Half of 2026
  • CytoSorbents expects operating cash flow breakeven in the second half of 2026, with profitability targeted for late 2027-2028.
  • Second-quarter 2026 operating cash burn was $200,000, excluding $200,000 in restructuring payments; quarter-end cash, cash equivalents and restricted cash totaled $5.9 million.
  • Quarterly revenue reached $9.6 million; cost reductions included a 23% headcount cut since September 2025.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CytoSorbents Corporation published the original content used to generate this news brief on November 07, 2026, and is solely responsible for the information contained therein.